Agomab Therapeutics NV - AGMB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | Redmile Group, LLC | 5.6% | 2,735,926 | View |
| May 15, 2026 | SCHEDULE 13G | Jeremy C. Green | 5.6% | 2,735,926 | View |
| May 15, 2026 | SCHEDULE 13G | Redmile Biopharma Investments III, L.P. | 5.6% | 2,735,926 | View |
| May 15, 2026 | SCHEDULE 13G | Cormorant Asset Management, LP | 5.01% | 2,465,348 | View |
| May 15, 2026 | SCHEDULE 13G | Bihua Chen | 5.01% | 2,465,348 | View |
| Apr 16, 2026 | SCHEDULE 13G | Pontifax VI G.P. L.P. | 6.8% | 3,305,846 | View |
| Apr 16, 2026 | SCHEDULE 13G | Pontifax Management 4 G.P. (2015) Ltd. | 6.8% | 3,305,846 | View |
| Apr 16, 2026 | SCHEDULE 13G | Ran Nussbaum | 6.8% | 3,305,846 | View |
| Apr 16, 2026 | SCHEDULE 13G | Tomer Kariv | 6.8% | 3,305,846 | View |
| Mar 06, 2026 | SCHEDULE 13G | FMR LLC | 10.0% | 4,873,680 | View |
| Mar 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 10.0% | 4,873,680 | View |
| Feb 17, 2026 | SCHEDULE 13D | — | 10.6% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.